The orally bioavailable hydrobromide salt of the racemic bicyclic phthalene derivative citalopram with antidepressant activity. As a selective serotonin reuptake inhibitor (SSRI), citalopram selectively inhibits the CNS neuronal reuptake of serotonin, thereby potentiating serotonergic activity in the central nervous system (CNS). This agent has minimal effects on the CNS neuronal reuptake of norepinephrine (NE) and dopamine (DA).
Learn more about Citalopram hydrobromide
- Dailymed label info
- Scientific articles
- Drug portal Citalopram hydrobromide
- toxicity info on Citalopram hydrobromide
- FDA Citalopram hydrobromide
Latest research (Pubmed)